Answers are grounded in this paper and cite their sources.
BACKGROUND: Cervical cancer screening in primary care is hindered by expert pathologist shortages and heavy diagnostic workloads, leading to fatigue-induced misdiagnoses. This study evaluated the diagnostic capacity, subpopulation robustness, and operational efficiency of an interpretable machine learning (ML) tool within a large Chinese healthcare network. METHODS: A retrospective database of 5,000 women was audited. Archived liquid-based cytology (LBC) digital slides were evaluated via a parallel validation channel: the LBC-NET pipeline versus a double-blind panel of senior cytopathologists. Diagnostic safety was tested by stratifying data across age, vaginal infections, and menopause conditions. Algorithmic transparency was quantified using game-theoretic Shapley Additive exPlanations (SHAP) and morphological feature tracking. Operational efficiency was evaluated via continuous cumulative distribution curves. SHAP analytics revealed that the nucleus-to-cytoplasmic ratio and nuclear hyperchromasia intensity were the core predictive metrics. Operationally, the ML system compressed the median slide-review time by 63.0%, escalating the daily screening capacity by 175% and reducing specialist referral consultations by 45.2%. CONCLUSION: The interpretable ML tool provides a reliable and fast clinical choice for massive cervical cancer screening.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: